Biocompatible phase invertable proteinaceous compositions...

Details Biocompatible phase invertable proteinaceous compositions... Biocompatible phase invertable proteinaceous compositions...

2011-01-18

2011-01-18

Kishore, Gollamudi S (Department: 1612)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

C424S400000, C424S422000, C604S264000, C623S001100

Reexamination Certificate

active

07871639

ABSTRACT:
Biocompatible phase invertable proteinaceous compositions and methods for making and using the same are provided. The subject phase invertable compositions are prepared by combining a proteinaceous substrate and a cross-linker. The proteinaceous substrate includes one or more proteins and an adhesion modifier, and may also include one or more of: a plasticizer, a carbohydrate, or other modification agent. In certain embodiments, the cross-linker is a heat-treated dialdehyde, e.g., heat-treated glutaraldehyde. Also provided are kits for use in preparing the subject compositions. The subject compositions, kits and systems find use in a variety of different applications.

REFERENCES:
patent: 3438374 (1969-04-01), Falb et al.
patent: 3559652 (1971-02-01), Banitt et al.
patent: 5092841 (1992-03-01), Spears
patent: 5219895 (1993-06-01), Kelman et al.
patent: 5292362 (1994-03-01), Bass et al.
patent: 5385606 (1995-01-01), Kowanko
patent: 5583114 (1996-12-01), Barrows et al.
patent: 5817303 (1998-10-01), Stedronsky et al.
patent: 5843156 (1998-12-01), Slepian et al.
patent: 6162241 (2000-12-01), Coury et al.
patent: 6290729 (2001-09-01), Slepian et al.
patent: 6299631 (2001-10-01), Shalaby
patent: 6302898 (2001-10-01), Edwards et al.
patent: 6310036 (2001-10-01), Browdie
patent: 6329337 (2001-12-01), Morita et al.
patent: 6371975 (2002-04-01), Cruise et al.
patent: 6372229 (2002-04-01), Ollerenshaw et al.
patent: 6423333 (2002-07-01), Stedronsky et al.
patent: 6458147 (2002-10-01), Cruise et al.
patent: 6475182 (2002-11-01), Hnojewyj et al.
patent: 6547806 (2003-04-01), Ding
patent: 6554851 (2003-04-01), Palasis et al.
patent: 6561970 (2003-05-01), Carpentier et al.
patent: 7303757 (2007-12-01), Schankereli et al.
patent: 2002/0015724 (2002-02-01), Yang et al.
patent: 2002/0022588 (2002-02-01), Wilkie et al.
patent: 2002/0133193 (2002-09-01), Ginn et al.
patent: 2002/0173770 (2002-11-01), Flory et al.
patent: 2002/0183244 (2002-12-01), Ollerenshaw et al.
patent: 2002/0198490 (2002-12-01), Wirt et al.
patent: 2003/0032143 (2003-02-01), Neff et al.
patent: 2003/0125813 (2003-07-01), Carpentier et al.
patent: 2004/0030405 (2004-02-01), Carpentier et al.
patent: 2425935 (2002-10-01), None
patent: 1043034 (2000-10-01), None
patent: 97/22372 (1997-06-01), None
patent: 01/45761 (2001-06-01), None
Prusiner, Stanley, “Prion Diseases and the BSE Crisis,” Sciences, vol. 278, 1997, p. 245-251.
Merck Index, 1983, pp. 641-642.

Affiliated with

Also associated with

Rating

Biocompatible phase invertable proteinaceous compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biocompatible phase invertable proteinaceous compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biocompatible phase invertable proteinaceous compositions... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2715404